Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
23
Number of overlapping holdings
10.3%
% of IBB's 260 holdings also in PBE
82.1%
% of PBE's 28 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 8.6% | 5.3% | 5.3% |
|
AMGEN INC | 8.4% | 5.0% | 5.0% |
|
REGENERON PHARMACEUTICALS | 7.2% | 4.4% | 4.4% |
|
NATERA INC | 2.3% | 5.4% | 2.3% |
|
BIOGEN IDEC INC | 2.1% | 4.7% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to PBE
|
VERTEX PHARMACEUTICALS INC | 9.6% |
|
ALNYLAM PHARMACEUTICALS INC | 3.5% |
|
AMGEN INC | 3.5% |
|
GILEAD SCIENCES INC | 3.3% |
 |
ARGENX SE ADR | 3.1% |
|
IQVIA HOLDINGS INC | 3.1% |
|
REGENERON PHARMACEUTICALS | 2.9% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.5% |
|
WATERS CORP | 2.3% |
 |
BIONTECH SE SPONSORED ADR | 2.0% |
IBB Underweight Relative to PBE
|
TG THERAPEUTICS INC | -4.0% |
|
NEUROCRINE BIOSCIENCES INC | -3.7% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.7% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
NATERA INC | -3.0% |
|
ROYALTY PHARMA PLC CLASS A | -3.0% |
|
UNITED THERAPEUTICS CORP | -3.0% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
ILLUMINA INC | -2.8% |
|
VERACYTE INC | -2.6% |